Radspherin
Phase 1/2Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Peritoneal Carcinoma
Conditions
Peritoneal Carcinoma, Colorectal Carcinoma
Trial Timeline
May 27, 2020 → May 14, 2025
NCT ID
NCT03732781About Radspherin
Radspherin is a phase 1/2 stage product being developed by Oncoinvent for Peritoneal Carcinoma. The current trial status is completed. This product is registered under clinical trial identifier NCT03732781. Target conditions include Peritoneal Carcinoma, Colorectal Carcinoma.
Hype Score Breakdown
Clinical
13
Activity
8
Company
2
Novelty
4
Community
3
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06504147 | Phase 2 | Recruiting |
| NCT03732768 | Phase 1 | Active |
| NCT03732781 | Phase 1/2 | Completed |
Competing Products
20 competing products in Peritoneal Carcinoma